Long distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF

Experimental Neurology

Volumn 250, Issue , 2013, Pages 156-164

  Zhang, C ^a   Jin, Y ^a,b   Ziemba, K S ^a   Fletcher, A M ^a   Ghosh, B ^c,d   Truit, E ^a   Yurek, D M ^a   Smith, G M ^a,c,d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d SHRINERS HOSPITALS FOR CHILDREN   (United States)

Author keywords

Axonal guidance; GDNF; Lentivirus; Netrin 1; Parkinson's disease; Tyrosine hydroxylase; Ventral mesencephalon (VM) transplantation

Indexed keywords

CILIARY NEUROTROPHIC FACTOR RECEPTOR ALPHA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA 1; LENTIVIRUS VECTOR; NETRIN 1; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS CALLOSUM; DOPAMINERGIC NERVE CELL; EMBRYO; FEMALE; LENTIVIRINAE; MESENCEPHALON; NERVE CELL NETWORK; NERVE FIBER GROWTH; NONHUMAN; NUCLEOTIDE SEQUENCE; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; VENTRAL MESENCEPHALON TRANSPLANTION;

AXONAL GUIDANCE; GDNF; LENTIVIRUS; NETRIN-1; PARKINSON'S DISEASE; TYROSINE HYDROXYLASE; VENTRAL MESENCEPHALON (VM) TRANSPLANTATION;

ANIMALS; AXONS; BLOTTING, WESTERN; BRAIN TISSUE TRANSPLANTATION; DOPAMINERGIC NEURONS; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MESENCEPHALON; MICE; NERVE GROWTH FACTORS; RATS; RATS, SPRAGUE-DAWLEY; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS;

EID: 84886006878     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.09.022     Document Type: Article

References (72)

1. Agrawal A.K., Chaturvedi R.K., Shukla S., Seth K., Chauhan S., Ahmad A., Seth P.K. Restorative potential of dopaminergic grafts in presence of antioxidants in rat model of Parkinson's disease. J. Chem. Neuroanat. 2004, 28:253-264.
2. Airaksinen M.S., Saarma M. The GDNF family: signalling, biological functions and therapeutic value. Nat. Rev. Neurosci. 2002, 3:383-394.
3. Blanchard B.C., Pelka B.M., Sladek J.R. A strategy for nigrostriatal tract reconstruction in response to striatal trophic factors. Cell Transplant. 2010, 19:332.
4. Bonner J.F., Connors T.M., Silverman W.F., Kowalski D.P., Lemay M.A., Fischer I. Grafted neural progenitors integrate and restore synaptic connectivity across the injured spinal cord. J. Neurosci. 2011, 31:4675-4686.
5. Braak H., Del Tredici K. Assessing fetal nerve cell grafts in Parkinson's disease. Nat. Med. 2008, 14:483-485.
6. Brecknell J.E., Du J.S., Muir E., Fidler P.S., Hlavin M.L., Dunnett S.B., Fawcett J.W. Bridge grafts of fibroblast growth factor-4-secreting schwannoma cells promote functional axonal regeneration in the nigrostriatal pathway of the adult rat. Neuroscience 1996, 74:775-784.
7. Brundin P., Pogarell O., Hagell P., Piccini P., Widner H., Schrag A., Kupsch A., Crabb L., Odin P., Gustavii B., Bjorklund A., Brooks D.J., Marsden C.D., Oertel W.H., Quinn N.P., Rehncrona S., Lindvall O. Bilateral caudate and putamen grafts of embryonic mesencephalic tissue treated with lazaroids in Parkinson's disease. Brain 2000, 123:1380-1390.
8. Chedotal A., Richards L.J. Wiring the brain: the biology of neuronal guidance. Cold Spring Harb. Perspect. Biol. 2010, 2:a001917.
9. Chiang Y., Morales M., Zhou F.C., Borlongan C., Hoffer B.J., Wang Y. Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemi-parkinsonian rats. Brain Res. 2001, 889:200-207.
10. Crone S.A., Lee K.F. The bound leading the bound: target-derived receptors act as guidance cues. Neuron 2002, 36:333-335.
11. Dickson B.J. Molecular mechanisms of axon guidance. Science 2002, 298:1959-1964.
12. Dunnett S.B., Rogers D.C., Richards S.J. Nigrostriatal reconstruction after 6-OHDA lesions in rats: combination of dopamine-rich nigral grafts and nigrostriatal "bridge" grafts. Exp. Brain Res. 1989, 75:523-535.
13. Erickson J.T., Brosenitsch T.A., Katz D.M. Brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo. J. Neurosci. 2001, 21:581-589.
14. Freed C.R., Greene P.E., Breeze R.E., Tsai W.Y., DuMouchel W., Kao R., Dillon S., Winfield H., Culver S., Trojanowski J.Q., Eidelberg D., Fahn S. Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 2001, 344:710-719.
15. Gaillard A., Decressac M., Frappe I., Fernagut P.O., Prestoz L., Besnard S., Jaber M. Anatomical and functional reconstruction of the nigrostriatal pathway by intranigral transplants. Neurobiol. Dis. 2009, 35:477-488.
16. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature 1996, 380:252-255.
17. Govek E.E., Newey S.E., Van Aelst L. The role of the Rho GTPases in neuronal development. Genes Dev. 2005, 19:1-49.
18. Grondin R., Gash D.M. Glial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's disease. J. Neurology 1998, 245:P35-42.
19. Guan K.L., Rao Y. Signalling mechanisms mediating neuronal responses to guidance cues. Nat. Rev. Neurosci. 2003, 4:941-956.
20. Huber A.B., Kolodkin A.L., Ginty D.D., Cloutier J.F. Signaling at the growth cone: ligand-receptor complexes and the control of axon growth and guidance. Annu. Rev. Neurosci. 2003, 26:509-563.
21. Hudson J., Granholm A.C., Gerhardt G.A., Henry M.A., Hoffman A., Biddle P., Leela N.S., Mackerlova L., Lile J.D., Collins F., et al. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 1995, 36:425-432.
22. Jin Y., Ziemba K.S., Smith G.M. Axon growth across a lesion site along a preformed guidance pathway in the brain. Exp. Neurol. 2008, 210:521-530.
23. Jin Y., Zhang C., Ziemba K.S., Goldstein G.A., Sullivan P.G., Smith G.M. Directing dopaminergic fiber growth along a preformed molecular pathway from embryonic ventral mesencephalon transplants in the rat brain. J. Neurosci. Res. 2011, 89:619-627.
24. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 1996, 85:1113-1124.
25. Johnson E.M., Taniuchi M., DiStefano P.S. Expression and possible function of nerve growth factor receptors on Schwann cells. Trends Neurosci. 1988, 11:299-304.
26. Keino-Masu K., Masu M., Hinck L., Leonardo E.D., Chan S.S., Culotti J.G., Tessier-Lavigne M. Deleted in Colorectal Cancer (DCC) encodes a netrin receptor. Cell 1996, 87:175-185.
27. Kennedy T.E., Serafini T., de la Torre J.R., Tessier-Lavigne M. Netrins are diffusible chemotropic factors for commissural axons in the embryonic spinal cord. Cell 1994, 78:425-435.
28. Kirik D., Georgievska B., Bjorklund A. Localized striatal delivery of GDNF as a treatment for Parkinson disease. Nat. Neurosci. 2004, 7:105-110.
29. Kordower J.H., Emborg M.E., Bloch J., Ma S.Y., Chu Y., Leventhal L., McBride J., Chen E.Y., Palfi S., Roitberg B.Z., Brown W.D., Holden J.E., Pyzalski R., Taylor M.D., Carvey P., Ling Z., Trono D., Hantraye P., Deglon N., Aebischer P. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. Science 2000, 290:767-773.
30. Kumar M., Keller B., Makalou N., Sutton R.E. Systematic determination of the packaging limit of lentiviral vectors. Hum. Gene Ther. 2001, 12:1893-1905.
31. Lebrand C., Dent E.W., Strasser G.A., Lanier L.M., Krause M., Svitkina T.M., Borisy G.G., Gertler F.B. Critical role of Ena/VASP proteins for filopodia formation in neurons and in function downstream of netrin-1. Neuron 2004, 42:37-49.
32. Ledda F., Paratcha G., Ibanez C.F. Target-derived GFRalpha1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5. Neuron 2002, 36:387-401.
33. Lin L., Isacson O. Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits. Stem Cells 2006, 24:2504-2513.
34. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 1993, 260:1130-1132.
35. Lin L., Rao Y., Isacson O. Netrin-1 and slit-2 regulate and direct neurite growth of ventral midbrain dopaminergic neurons. Mol. Cell. Neurosci. 2005, 28:547-555.
36. Lindvall O., Kokaia Z. Stem cells in human neurodegenerative disorders-time for clinical translation?. J. Clin. Invest. 2010, 120:29-40.
37. Liu G., Li W., Wang L., Kar A., Guan K.L., Rao Y., Wu J.Y. DSCAM functions as a netrin receptor in commissural axon pathfinding. Proc. Natl. Acad. Sci. 2009, 106:2951-2956.
38. Luo L. Actin cytoskeleton regulation in neuronal morphogenesis and structural plasticity. Annu. Rev. Cell Dev. Biol. 2002, 18:601-635.
39. Ly A., Nikolaev A., Suresh G., Zheng Y., Tessier-Lavigne M., Stein E. DSCAM is a netrin receptor that collaborates with DCC in mediating turning responses to netrin-1. Cell 2008, 133:1241-1254.
40. Ma C.H., Bampton E.T., Evans M.J., Taylor J.S. Synergistic effects of osteonectin and brain-derived neurotrophic factor on axotomized retinal ganglion cells neurite outgrowth via the mitogen-activated protein kinase-extracellular signal-regulated kinase 1/2 pathways. Neuroscience 2010, 165:463-474.
41. Madduri S., Papaloizos M., Gander B. Synergistic effect of GDNF and NGF on axonal branching and elongation in vitro. Neurosci. Res. 2009, 65:88-97.
42. Madduri S., di Summa P., Papaloizos M., Kalbermatten D., Gander B. Effect of controlled co-delivery of synergistic neurotrophic factors on early nerve regeneration in rats. Biomaterials 2010, 31:8402-8409.
43. Manitt C., Colicos M.A., Thompson K.M., Rousselle E., Peterson A.C., Kennedy T.E. Widespread expression of netrin-1 by neurons and oligodendrocytes in the adult mammalian spinal cord. J. Neurosci. 2001, 21:3911-3922.
44. Manitt C., Labelle-Dumais C., Eng C., Grant A., Mimee A., Stroh T., Flores C. Peri-pubertal emergence of UNC-5 homologue expression by dopamine neurons in rodents. PLoS One 2010, 5:e11463.
45. Moore S.W., Tessier-Lavigne M., Kennedy T.E. Netrins and their receptors. Adv. Exp. Med. Biol. 2007, 621:17-31.
46. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F.H., Verma I.M., Trono D. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 1996, 272:263-267.
47. Nielsen J., Gotfryd K., Li S., Kulahin N., Soroka V., Rasmussen K.K., Bock E., Berezin V. Role of glial cell line-derived neurotrophic factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF. J. Neurosci. 2009, 29:11360-11376.
48. Nikkhah G., Bentlage C., Cunningham M.G., Bjorklund A. Intranigral fetal dopamine grafts induce behavioral compensation in the rat Parkinson model. J. Neurosci. 1994, 14:3449-3461.
49. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M.G., Bjorklund A. A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 1994, 63:57-72.
50. Nikkhah G., Cunningham M.G., Cenci M.A., McKay R.D., Bjorklund A. Dopaminergic microtransplants into the substantia nigra of neonatal rats with bilateral 6-OHDA lesions. I. Evidence for anatomical reconstruction of the nigrostriatal pathway. J. Neurosci. 1995, 15:3548-3561.
51. Osborne P.B., Halliday G.M., Cooper H.M., Keast J.R. Localization of immunoreactivity for deleted in colorectal cancer (DCC), the receptor for the guidance factor netrin-1, in ventral tier dopamine projection pathways in adult rodents. Neuroscience 2005, 131:671-681.
52. Paratcha G., Ledda F. GDNF and GFRalpha: a versatile molecular complex for developing neurons. Trends Neurosci. 2008, 31:384-391.
53. Paratcha G., Ledda F., Baars L., Coulpier M., Besset V., Anders J., Scott R., Ibanez C.F. Released GFRalpha1 potentiates downstream signaling, neuronal survival, and differentiation via a novel mechanism of recruitment of c-Ret to lipid rafts. Neuron 2001, 29:171-184.
54. Paratcha G., Ledda F., Ibanez C.F. The neural cell adhesion molecule NCAM is an alternative signaling receptor for GDNF family ligands. Cell 2003, 113:867-879.
55. Pierchala B.A., Milbrandt J., Johnson E.M. Glial cell line-derived neurotrophic factor-dependent recruitment of Ret into lipid rafts enhances signaling by partitioning Ret from proteasome-dependent degradation. J. Neurosci. 2006, 26:2777-2787.
56. Pruszak J., Just L., Isacson O., Nikkhah G. Isolation and culture of ventral mesencephalic precursor cells and dopaminergic neurons from rodent brains. Curr. Protoc. Stem Cell Biol. 2009, (Chapter 2, Unit 2D 5).
57. Redmond D.E., Elsworth J.D., Roth R.H., Leranth C., Collier T.J., Blanchard B., Bjugstad K.B., Samulski R.J., Aebischer P., Sladek J.R. Embryonic substantia nigra grafts in the mesencephalon send neurites to the host striatum in non-human primate after overexpression of GDNF. J. Comp. Neurol. 2009, 515:31-40.
58. Rosenblad C., Martinez-Serrano A., Bjorklund A. Glial cell line-derived neurotrophic factor increases survival, growth and function of intrastriatal fetal nigral dopaminergic grafts. Neuroscience 1996, 75:979-985.
59. Round J., Stein E. Netrin signaling leading to directed growth cone steering. Curr. Opin. Neurobiol. 2007, 17:15-21.
60. Sautter J., Meyer M., Spenger C., Seiler R.W., Widmer H.R. Effects of combined BDNF and GDNF treatment on cultured dopaminergic midbrain neurons. Neuroreport 1998, 9:1093-1096.
61. Taylor J.R., Elsworth J.D., Roth R.H., Sladek J.R., Collier T.J., Redmond D.E. Grafting of fetal substantia nigra to striatum reverses behavioral deficits induced by MPTP in primates: a comparison with other types of grafts as controls. Exp. Brain Res. 1991, 85:335-348.
62. Thompson L.H., Grealish S., Kirik D., Bjorklund A. Reconstruction of the nigrostriatal dopamine pathway in the adult mouse brain. Eur. J. Neurosci. 2009, 30:625-638.
63. Tomac A., Lindqvist E., Lin L.F., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 1995, 373:335-339.
64. Wakeman D.R., Dodiya H.B., Kordower J.H. Cell transplantation and gene therapy in Parkinson's disease. Mt. Sinai J. Med. 2011, 78:126-158.
65. Wang Y., Tien L.T., Lapchak P.A., Hoffer B.J. GDNF triggers fiber outgrowth of fetal ventral mesencephalic grafts from nigra to striatum in 6-OHDA-lesioned rats. Cell Tissue Res. 1996, 286:225-233.
66. Wilby M.J., Sinclair S.R., Muir E.M., Zietlow R., Adcock K.H., Horellou P., Rogers J.H., Dunnett S.B., Fawcett J.W. A glial cell line-derived neurotrophic factor-secreting clone of the Schwann cell line SCTM41 enhances survival and fiber outgrowth from embryonic nigral neurons grafted to the striatum and to the lesioned substantia nigra. J. Neurosci. 1999, 19:2301-2312.
67. Xu B., Goldman J.S., Rymar V.V., Forget C., Lo P.S., Bull S.J., Vereker E., Barker P.A., Trudeau L.E., Sadikot A.F., Kennedy T.E. Critical roles for the netrin receptor deleted in colorectal cancer in dopaminergic neuronal precursor migration, axon guidance, and axon arborization. Neuroscience 2010, 169:932-949.
68. Yee K.T., Simon H.H., Tessier-Lavigne M., O'Leary D.M. Extension of long leading processes and neuronal migration in the mammalian brain directed by the chemoattractant netrin-1. Neuron 1999, 24:607-622.
69. Yurek D.M. Intranigral transplants of fetal ventral mesencephalic tissue attenuate D1-agonist-induced rotational behavior. Exp. Neurol. 1997, 143:1-9.
70. Yurek D.M. Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp. Neurol. 1998, 153:195-202.
71. Yurek D.M., Fletcher A.M., Smith G.M., Seroogy K.B., Ziady A.G., Molter J., Kowalczyk T.H., Padegimas L., Cooper M.J. Long-term transgene expression in the central nervous system using DNA nanoparticles. Mol. Ther. 2009, 17:641-650.
72. Ziemba K.S., Chaudhry N., Rabchevsky A.G., Jin Y., Smith G.M. Targeting axon growth from neuronal transplants along preformed guidance pathways in the adult CNS. J. Neurosci. 2008, 28:340-348.